Grifols shares rise on talks of potential takeover bid from Brookfield
** Shares of Spanish Grifols GRLS.MC jump more than 20% after the drugmaker confirms a media report regarding potential takeover bid negotiations with Canadian fund Brookfield BN.TO
** Grifols says it is uncertain whether the transaction will occur, but adds the bid entails delisting
** Specific terms of the transaction remain unknown
** In a separate statement, Brookfield informs about exclusivity agreement signed with its shareholders to assess the potential transaction
** Spanish newspaper Cinco Dias reported on Sunday the deal could be worth around 5.5 billion euros ($5.95 billion), in line with the company's market cap at Friday's close
** JP Morgan highlights the bid and price are still uncertain, but adds the suggested 5.5 bln euros may not benefit current shareholders
** Spanish regulator CNMV halted Grifols' trading shortly before the market open until 12:00 CEST
** Up to the previous session's close, shares were down 41.8% year-to-date
** Shares on track for best day ever, and including session's rise, stock down 30.09% YTD
($1 = 0.9240 euros)
Reporting by Marta Serafinko
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
